Vor Biopharma Inc. (VOR) Institutional Ownership

Ownership Summary

Vor Biopharma Inc. (NASDAQ:VOR) appears in 34 institutional 13F filings for the quarter ending June 2025.

• They owned 910.5% of outstanding stock in June 2025, down from 968.6% the prior quarter.
• Their total shares held in VOR decreased -3.46% quarter over quarter, and separately, investors owning Vor Biopharma decreased 52.78% from a year ago.
• During the quarter, 15 of these 34 funds increased positions in VOR, 10 reduced exposure, and 9 held steady.
• Combined, these investors held 57.03Mn shares in VOR for June 2025, down by 2.04Mn shares quarter on quarter, and up 2.01Mn shares year over year.
• As of June 30, 2025, the biggest holder of Vor Biopharma is TCG Crossover Management, LLC at 5.67Mn shares, representing 90.57% of shares outstanding.
• Leading buyers of Vor Biopharma shares for the quarter ending June 2025 were TCG Crossover Management, LLC (5.67Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.43Mn), MARSHALL WACE, LLP (1.15Mn), Venrock Adviser, LLC (1.1Mn), State Street Corp (1.03Mn).
• Top sellers of VOR stock for the quarter ending June 2025 included FMR LLC (986.5K), Laurion Capital Management LP (315.82K), CITADEL ADVISORS LLC (285.13K), SPHERA FUNDS MANAGEMENT LTD. (88.5K), Johnson & Johnson (53.73K).
• According to Business Quant data, leading holders of VOR for June 2025 are TCG Crossover Management, LLC (5.67Mn), RA CAPITAL MANAGEMENT, L.P. (5.4Mn), FCPM III SERVICES B.V. (4.12Mn), Venrock Adviser, LLC (3.04Mn), Frazier Life Sciences Management, L.P. (2.54Mn), Caligan Partners LP (1.93Mn), Paradigm Biocapital Advisors LP (1.75Mn), GREAT POINT PARTNERS LLC (1.75Mn), FMR LLC (1.54Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.43Mn).